Diamond Biofund Inc.

Taiwan Stock Exchange 6901.TW

Diamond Biofund Inc. Gross Profit for the year ending December 31, 2023: USD -247.82 K

Diamond Biofund Inc. Gross Profit is USD -247.82 K for the year ending December 31, 2023, a -100.75% change year over year. Gross profit is the difference between revenue and the cost of revenue, representing the profit earned from core business operations.
  • Diamond Biofund Inc. Gross Profit for the year ending December 31, 2022 was USD 33.13 M, a 0.00% change year over year.
  • Diamond Biofund Inc. Gross Profit for the year ending December 31, 2021 was USD 0.00, a 0.00% change year over year.
  • Diamond Biofund Inc. Gross Profit for the year ending December 31, 2020 was USD 0.00, a 0.00% change year over year.
  • Diamond Biofund Inc. Gross Profit for the year ending December 31, 2019 was USD 0.00.
Key data
Date Gross Profit Operating Income EBIT EBITDA
Market news
Taiwan Stock Exchange: 6901.TW

Diamond Biofund Inc.

CEO Mr. Pan-Chih Yang
IPO Date Sept. 11, 2023
Location
Headquarters 34th Floor
Employees 28
Sector Finance
Industries
Venture Capital Biotechnology
Description

Diamond Biofund Inc. is a venture capital firm specializing in evergreen funds. The firm seeks investment in start-ups and early ventures. It typically invests in biotechnology and medical investments, including new drug R&D, high-end medical equipment, innovative medical services and channels, and agricultural biotechnology. Diamond Biofund Inc. was founded in 2013 and is based in Taipei, Taiwan.

StockViz Staff

January 15, 2025

Any question? Send us an email